Perspective
Published in:
Volume 1 / Year 2012 / Issue 2
Volume 1 / Year 2012 / Issue 2
Generic clopidogrel–the medicines agency’s perspective
Author(s): Christoph Baumgärtel, MD, MSc
Page: 89-91
Page: 89-91
Abstract: A number of generic products containing clopidogrel as the active substance have been marketed in Austria and the EU for some time. Due to different clopidogrel salt preparations and different indications, doubts… Read More »
Promoting access to biosimilars: a public−private partnership model for biosimilar development in underserved populations
Author byline as per print journal: Timothy Ken Mackey1,2, MAS; Professor Bryan A Liang1,3,4, MD, JD, PhD Abstract: Biologicals represent the future of pharmaceutical treatments and innovation. Yet, emerging and developing… Read More »